Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole versus other second-generation antipsychotics for acute mania
IRCT20110819007373N8Phase 4Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-blind trial of aripiprazole in bipolar I disorder and mania (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Symptoms of acute mania. Started Dec 2018; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disordermania
Beyond the preview
Go deeper on IRCT20110819007373N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110819007373N8.